These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1387883)
21. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. Leo O; Sachs DH; Samelson LE; Foo M; Quinones R; Gress R; Bluestone JA J Immunol; 1986 Dec; 137(12):3874-80. PubMed ID: 3097135 [TBL] [Abstract][Full Text] [Related]
22. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL. Lancki DW; Kaper BP; Fitch FW J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047 [TBL] [Abstract][Full Text] [Related]
24. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791 [TBL] [Abstract][Full Text] [Related]
25. Temperature requirements and kinetics of T cell signaling. Velocity of triggering correlates with functional effects of anti-CD3 mAb. Abdi K; Reed ML; Mentzer SJ; Herrmann SH J Immunol; 1989 May; 142(9):2971-80. PubMed ID: 2468707 [TBL] [Abstract][Full Text] [Related]
26. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083 [TBL] [Abstract][Full Text] [Related]
27. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371. Chen ZJ; Yang H; Kageshita T; Ferrone S Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513 [TBL] [Abstract][Full Text] [Related]
28. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. Giacomini P; Natali P; Ferrone S J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052 [TBL] [Abstract][Full Text] [Related]
29. Lysis of cells infected with HIV-1 by human lymphocytes targeted with monoclonal antibody heteroconjugates. Zarling JM; Moran PA; Grosmaire LS; McClure J; Shriver K; Ledbetter JA J Immunol; 1988 Apr; 140(8):2609-13. PubMed ID: 2965725 [TBL] [Abstract][Full Text] [Related]
30. Enhanced in vitro lysis of human ovarian carcinomas with activated peripheral blood lymphocytes and bifunctional immune heteroaggregates. Donohue JH; Ramsey PS; Kerr LA; Segal DM; McKean DJ Cancer Res; 1990 Oct; 50(20):6508-14. PubMed ID: 2145062 [TBL] [Abstract][Full Text] [Related]
31. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Gervois N; Heuze F; Diez E; Jotereau F Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794 [TBL] [Abstract][Full Text] [Related]
32. Retargeting of cytolytic T lymphocytes by heteroaggregated (bispecific) antibodies. Barr IG; Buchegger F; MacDonald HR; Carrel S; von Fliedner V Cancer Detect Prev; 1988; 12(1-6):439-50. PubMed ID: 3263199 [TBL] [Abstract][Full Text] [Related]
34. Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor. Reinhold U; Liu L; Lüdtke-Handjery HC; Heuser C; Hombach A; Wang X; Tilgen W; Ferrone S; Abken H J Invest Dermatol; 1999 May; 112(5):744-50. PubMed ID: 10233766 [TBL] [Abstract][Full Text] [Related]
35. Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components. Mezzanzanica D; Canevari S; Ménard S; Pupa SM; Tagliabue E; Lanzavecchia A; Colnaghi MI Int J Cancer; 1988 Apr; 41(4):609-15. PubMed ID: 3258590 [TBL] [Abstract][Full Text] [Related]
36. Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies. Barr IG; MacDonald HR; Buchegger F; von Fliedner V Int J Cancer; 1987 Sep; 40(3):423-9. PubMed ID: 3497884 [TBL] [Abstract][Full Text] [Related]
37. Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells. Liu MA; Nussbaum SR; Eisen HN Science; 1988 Jan; 239(4838):395-8. PubMed ID: 3257303 [TBL] [Abstract][Full Text] [Related]
38. Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy. Slingluff CL; Darrow TL; Seigler HF Ann Surg; 1989 Aug; 210(2):194-202. PubMed ID: 2787972 [TBL] [Abstract][Full Text] [Related]
39. Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex. Ito M; Usuba O; Unkeless JC; Schreiber R; Celada F; Bona CA; Moran TM Scand J Immunol; 1989 Jun; 29(6):659-69. PubMed ID: 2525807 [TBL] [Abstract][Full Text] [Related]
40. Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes. Mansfield PF; Salmeron MA; Rosenblum MG; Itoh K Int J Cancer; 1991 Sep; 49(3):356-61. PubMed ID: 1917133 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]